Psyence Biomedical Statistics
Total Valuation
PBM has a market cap or net worth of $11.33 million. The enterprise value is $3.85 million.
Important Dates
The next estimated earnings date is Friday, July 17, 2026, before market open.
| Earnings Date | Jul 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PBM has 3.81 million shares outstanding. The number of shares has increased by 1,688.07% in one year.
| Current Share Class | 3.81M |
| Shares Outstanding | 3.81M |
| Shares Change (YoY) | +1,688.07% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.58% |
| Owned by Institutions (%) | 5.28% |
| Float | 2.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.37 |
| P/TBV Ratio | 0.67 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.62
| Current Ratio | 14.62 |
| Quick Ratio | 12.12 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -655.06 |
Financial Efficiency
Return on equity (ROE) is -58.62% and return on invested capital (ROIC) is -32.95%.
| Return on Equity (ROE) | -58.62% |
| Return on Assets (ROA) | -31.33% |
| Return on Invested Capital (ROIC) | -32.95% |
| Return on Capital Employed (ROCE) | -36.81% |
| Weighted Average Cost of Capital (WACC) | 13.35% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$578,035 |
| Employee Count | 12 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -90.36% in the last 52 weeks. The beta is 1.65, so PBM's price volatility has been higher than the market average.
| Beta (5Y) | 1.65 |
| 52-Week Price Change | -90.36% |
| 50-Day Moving Average | 4.99 |
| 200-Day Moving Average | 8.95 |
| Relative Strength Index (RSI) | 37.00 |
| Average Volume (20 Days) | 76,908 |
Short Selling Information
The latest short interest is 25,988, so 0.68% of the outstanding shares have been sold short.
| Short Interest | 25,988 |
| Short Previous Month | 71,272 |
| Short % of Shares Out | 0.68% |
| Short % of Float | 1.00% |
| Short Ratio (days to cover) | 0.35 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -6.24M |
| Pretax Income | -6.94M |
| Net Income | -6.94M |
| EBITDA | -6.23M |
| EBIT | -6.24M |
| Earnings Per Share (EPS) | -$12.56 |
Full Income StatementBalance Sheet
The company has $7.44 million in cash and n/a in debt, giving a net cash position of $7.44 million or $1.95 per share.
| Cash & Cash Equivalents | 7.44M |
| Total Debt | n/a |
| Net Cash | 7.44M |
| Net Cash Per Share | $1.95 |
| Equity (Book Value) | 16.94M |
| Book Value Per Share | 7.39 |
| Working Capital | 8.49M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$8.14 million and capital expenditures -$229, giving a free cash flow of -$8.14 million.
| Operating Cash Flow | -8.14M |
| Capital Expenditures | -229 |
| Depreciation & Amortization | 5,266 |
| Net Borrowing | n/a |
| Free Cash Flow | -8.14M |
| FCF Per Share | -$2.13 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |